VCANBIO
60064518.681.52% ( +0.28 )
VCANBIO (600645)
Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People’s Repub...
- Open
- 18.49
- High
- 18.84
- Low
- 18.25
- Prev. Close
- 18.40
- Volume
- 78.56K
- Turnover
- 146.20M
- Avg Price
- 18.61
- Bid/Ask Ratio
- --
- Amplitude
- 3.21%
- 52wk High
- 32.99
- Volume Ratio
- 0.62
- Turnover Ratio
- 1.68%
VCANBIO Analyst Rating
View MoreForecast & Rating
Dec 30, 2024Price forecast
--100.00%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 12, 2025 at 10:22 PM
The national key research and development project participated by VCANBIO has been officially approved by the Ministry of Science and Technology
- Zhitong · Sep 9, 2025 at 05:21 AM
VCANBIO's subsidiary VUM02 injection has been approved for clinical trials
- Zhitong · Aug 27, 2025 at 04:50 AM
VCANBIO: Net profit of 57.7705 million yuan in the first half of 2025, a year-on-year decrease of 32.18%
- Zhitong · Jul 29, 2025 at 06:12 AM
VCANBIO plans to acquire a 25% stake in Shanghai Zhongyuan Jisheng Company
- Zhitong · Jun 25, 2025 at 04:21 AM
VCANBIO has reached a strategic cooperation with Carbon Cloud Intelligence
- Zhitong · Jun 23, 2025 at 05:13 AM
VCANBIO's subsidiary VUM02 injection clinical trial application has received an acceptance notice
